Patent details
EP2230254 Title: Anti-IGFR1 antibody therapeutic combinations
Basic Information
- Publication number:
- EP2230254
- PCT Application Number:
- Type:
- European Patent Granted for LU
- Legal Status:
- Lapsed
- Application number:
- EP101602605
- PCT Publication Number:
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- Anti-IGFR1 antibody therapeutic combinations
- French Title of Invention:
- Combinaisons thérapeutiques d'anticorps anti-igfr1
- German Title of Invention:
- Therapeutische anti-igfr1-Antikörper-Kombinationen
- SPC Number:
Dates
- Filing date:
- 19/11/2004
- Grant date:
- 15/05/2013
- EP Publication Date:
- 15/05/2013
- PCT Publication Date:
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 22/09/2010
- EP B1 Publication Date:
- 15/05/2013
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- 19/11/2013
- Expiration date:
- 19/11/2024
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 19/11/2004
- Name:
- Merck Sharp & Dohme Corp.
- Address:
- 126 East Lincoln Avenue, Rahway, NJ 07065-0907, United States (US)
Inventor
1
- Name:
- Wang Yan
- Address:
- United States (US)
2
- Name:
- Bishop Walter Robert
- Address:
- United States (US)
3
- Name:
- Pachter Jonathan A
- Address:
- United States (US)
Priority
- Priority Number:
- 524732 P
- Priority Date:
- 21/11/2003
- Priority Country:
- United States (US)
Classification
- Main IPC Class:
- C07K 16/28;
| Filing date | Document type | Number of pages |
|---|